Ispire Technology Inc. Announces Opening of New ISO- and GMP-Certified Malaysia Manufacturing Facility

State-of-the-Art Facility to Boost Production of Premium Vaporizers, Cartridges, Pod Systems, Disposables and Batteries for Global Vapor Industry

LOS ANGELES, Feb. 5, 2024 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a leader in the development and commercialization of vaping technology and precision dosing, announced the opening of its new ISO- and GMP-certified 31,000 sq. ft. manufacturing facility in Malaysia, which is poised to help expedite market entry for businesses seeking to enhance their cannabis and nicotine product lines.

Located in Senai, Ispire's facility recently secured certifications including: ISO9001:2015 Quality Management System; ISO14001:2015 Environmental Management System; and ISO13485:2016 Quality Management System Medical Device. Adhering to strict guidelines and standards, the Malaysian facility also encompasses a robust GMP-certified infrastructure, featuring a Quality Management System (QMS), Standard Operating Procedures (SOPs), Material Control and Traceability, Quality Control and Testing, Validation and Qualification, Cleanrooms, Environmental Monitoring, Compliance with Regulatory Requirements and Risk Management Protocols. In addition, the leadership at Ispire has committed to a continuous improvement strategy through regular audits, assessments and feedback mechanisms to optimize and enhance the facility.

"The inauguration of our ISO- and GMP-certified vapor device facility in Malaysia marks a significant milestone in our Company's journey," said Ispire Technology Co-Chief Executive Officer Michael Wang. "As the global vapor industry expands, our customers require a responsible and cost-effective partner to scale their operations, ensuring the production of safe, consistent and high-quality products. This facility adheres to established standards and reflects the dedication of our team in establishing a manufacturing facility that sets the worldwide industry standard for vaporized products."

Wang continued, "As we progress towards full production capacity, our owned-and-operated, ISO- and GMP-certified factory will enable us to realize profits from product assembly, a process that we previously outsourced. The absence of tariffs incurred during the assembly of products in Malaysia ? in contrast to the 25% tariff from shipping finished products from China ? is also expected to improve our gross margin and drive operational efficiencies that contribute to the overall growth."

About Ispire Technology Inc.

Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 200 patents received or filed globally. Ispire's tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company's cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware only in the U.S., and it recently commenced its marketing activities in Canada and Europe. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Facebook, Twitter and YouTube.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONEtm, Ispire ONEtm's success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONEtm and the success of their products on the markets; the Ispire ONEtm proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

IR Contacts:
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
[email protected]

KCSA Strategic Communications
212.896.1233
[email protected]

PR Contact:
Ellen Mellody
570.209.2947
[email protected]

SOURCE Ispire Technology Inc.